Having a sick child is a huge worry for parents, and it is even worse if getting to the bottom of what is wrong involves putting the child through a distressing procedure.
Kidney reflux is the most common urological disorder in childhood, affecting 2 per cent of young children. It is most prevalent from six months to five years of age. The condition may resolve as the child gets older, but left undiagnosed and untreated it can lead to permanent kidney damage and ultimately to kidney failure.
As of now diagnosing the condition is painful and invasive, and takes place in a hospital setting.
Sarah Loughney is a bioengineer who became familiar with difficulties surrounding the diagnosis of kidney reflux while participating in the Enterprise Ireland-backed BioInnovate Fellowship programmed in 2012. This programme encourages participants to develop medical innovations to meet identified clinical needs.
Loughney has now developed a non-invasive diagnostic solution for kidney reflux that removes the need for complicated procedures and a hospital visit.
Read the full article at The Irish Times
Applications are now open for the Biodesign Innovation Fellowship for 2016-17. The poster below is linked to the website for further information.
The Minister for Research and Innovation, Mr. Damien English T.D., has congratulated Trinity College Dublin, University of Limerick and their enterprise partners on their success in being part of the winning consortia for the two new KICs – large scale innovation partnerships - that were announced yesterday by the European Institute for Innovation and Technology (EIT).
The two new KICs are in the areas of Health and Raw Materials and will aim to boost the EU’s innovation capacity in what are seen as two of the key societal challenges facing Europe. The two partnerships will become fully operational in 2015.
The Minister said “I am delighted that Irish researchers and companies will be involved in these large scale European innovation projects. It is a recognition of the research and innovation capacity in Ireland that it has been successful in not just one of the consortia, but in both of the consortia chosen by the EIT. It is also the results of a 3 year strategy by Enterprise Ireland to ensure Irish participation in such large strategic European initiatives”.
“Involvement in these projects not only brings with it significant funding, but it also allows Irish researchers and companies to collaborate with the best in Europe on finding innovative solutions to some of the most significant challenges facing Europe today.”
The decision by the EIT Board was made following a shortlisting of consortia by independent international experts. The overriding criteria for selecting these consortia was excellence, and their impact in terms of business creation, entrepreneurship education and societal benefits.
These two KICs join the initial three KICs that were approved by the EIT in 2009. The EIT with a budget of €2.7 billion is an important part of the Horizon 2020 programme, which is the EU’s €80bn research programme that commenced in 2014 and will run to 2020. The Horizon 2020 programme offers significant opportunities for Ireland’s researchers and companies through its competitive funding calls.
In recognising the strategic importance of being part of the EIT is 2 such key areas, Enterprise Ireland supported Trinity College Dublin to bring together and lead the Irish partnerships in both areas. The Minister also stated that “This investment has now paid off and will reap rewards into the future, not only in positioning Ireland in 2 key very large scale initiatives, but also as an innovation player in Europe, attracting the best and brightest to join the successful participants. Involvement in the EIT is expected to open up opportunities across Europe for Irish SMEs who will have privileged access to other leading European players in their area”.
A device with potential to improve the outcomes from vascular surgery has won the Clinical Innovation Award 2014, sponsored by Enterprise Ireland in association with Cleveland Clinic. The winner, Dr. Cliona Murphy, a General Practitioner and current participant in the BioInnovate programme in National University of Ireland Galway, collaborated with colleagues to identify a technology that will make it easier for doctors to access the body during vascular surgery, and potentially improve outcomes for patients as a result.
Extending his congratulations to Dr. Murphy, Richard Bruton TD, Minister for Jobs, Enterprise and Innovation said, ‘Life sciences is a key part of our Action Plan for Jobs, and since taking office we have put in place a range of measures to support more Irish companies in this area. Dr. Murphy’s vascular surgical device is another great example of the brilliant ideas and businesses that are emerging every year from collaborative research with our Higher Education Institutions. I am delighted to congratulate her on this award, and look forward to working with her in the future”.
The Clinical Innovation Award, now in its 4th year, recognises commercial potential in Ireland’s clinical community, encouraging clinicians to engage in the development of new healthcare products and services that will improve patient care and benefit both the health care system and Ireland’s medical technologies companies.
Former BioInnovate Fellows secure €3m in Funding for start-up EMBO Medical. Full stroy from The Irish Times:
To get in touch with BioInnovate Ireland email us or see our contact details.
Learn about the Irish Medical Technology Sector by reading our key facts article.